CONCLUSIONS: The misuse of intravenous BPNX was linked to significant psychiatric comorbidity, unsafe injection practices, and a high burden of infectious diseases. The persistence of diversion despite the BPNX combination formulation suggests the current naloxone dose ratio may not be effective as a deterrent. Urgent integrated addiction, psychiatric, and harm-reduction services are needed.
